HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Massimo Claudio Fantini Selected Research
Massimo Claudio Fantini Research Topics
Disease
14
Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
12/2023 - 01/2007
8
Ulcerative Colitis
12/2023 - 08/2010
8
Inflammation (Inflammations)
12/2023 - 01/2007
7
Crohn Disease (Crohn's Disease)
12/2023 - 06/2009
4
Neoplasms (Cancer)
09/2020 - 06/2008
4
Colitis
01/2018 - 06/2009
4
Colonic Neoplasms (Colon Cancer)
10/2011 - 02/2008
3
Colitis-Associated Neoplasms
05/2021 - 10/2011
3
Colorectal Neoplasms (Colorectal Cancer)
01/2010 - 02/2008
1
Fistula
01/2023
1
Ageusia (Hypogeusia)
05/2021
1
Anosmia
05/2021
1
Fever (Fevers)
05/2021
1
Infections
05/2021
1
Non-alcoholic Fatty Liver Disease
01/2021
1
Fatty Liver
01/2021
1
Obesity
01/2021
1
Breast Neoplasms (Breast Cancer)
09/2020
1
Melanoma (Melanoma, Malignant)
09/2020
1
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2020
1
COVID-19
01/2020
1
Pneumonia (Pneumonitis)
01/2020
1
Venous Thromboembolism
01/2020
1
Carcinogenesis
01/2010
1
Bacterial Infections (Bacterial Infection)
02/2008
1
Hypersensitivity (Allergy)
03/2007
Drug/Important Bio-Agent (IBA)
9
Cytokines
IBA
12/2023 - 01/2007
5
Adalimumab (Humira)
FDA Link
01/2023 - 01/2019
5
Infliximab (Remicade)
FDA Link
01/2023 - 01/2019
5
Interleukins
IBA
03/2012 - 01/2007
4
vedolizumab
IBA
01/2023 - 10/2019
4
interleukin-21 (interleukin 21)
IBA
10/2011 - 01/2007
4
Mesalamine (Mesalazine)
FDA Link
Generic
10/2011 - 02/2008
3
Interleukin-17 (Interleukin 17)
IBA
10/2011 - 02/2008
2
Antigens
IBA
12/2023 - 09/2020
2
Ustekinumab (CNTO 1275)
FDA Link
01/2023 - 04/2022
2
Monoclonal Antibodies
IBA
01/2023 - 09/2020
2
golimumab
FDA Link
04/2022 - 01/2019
2
Proteins (Proteins, Gene)
FDA Link
01/2018 - 06/2008
2
Interleukin-13
IBA
03/2012 - 06/2009
2
Acids
IBA
03/2012 - 06/2009
2
Azoxymethane
IBA
10/2011 - 01/2010
2
Dextran Sulfate
IBA
10/2011 - 01/2010
2
2-methoxy-5-amino-N-hydroxybenzamide
IBA
10/2011 - 01/2010
1
Suspensions
IBA
01/2023
1
Antigen-Antibody Complex (Immune Complex)
IBA
01/2023
1
COVID-19 Vaccines
IBA
01/2023
1
tofacitinib
IBA
04/2022
1
Immunoglobulin G (IgG)
IBA
05/2021
1
C-Reactive Protein
IBA
01/2021
1
Lipids
IBA
01/2021
1
Biomarkers (Surrogate Marker)
IBA
01/2021
1
Leukocyte L1 Antigen Complex (Calgranulin)
IBA
01/2021
1
Integrins
IBA
09/2020
1
Adrenal Cortex Hormones (Corticosteroids)
IBA
01/2020
1
Biosimilar Pharmaceuticals
IBA
01/2019
1
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
01/2019
1
NAD (NADH)
IBA
01/2018
1
Sirtuin 1
IBA
01/2018
1
Chemokine CCL20
IBA
05/2017
1
Antisense Oligonucleotides
IBA
05/2017
1
GED0301
IBA
05/2017
1
Interleukin-4 (Interleukin 4)
IBA
03/2012
1
Transforming Growth Factor beta (TGF-beta)
IBA
03/2012
1
Antibodies
IBA
03/2012
1
Interleukin-6 (Interleukin 6)
IBA
10/2011
1
STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)
IBA
10/2011
1
TNF-Related Apoptosis-Inducing Ligand Receptors
IBA
10/2011
1
Survivin
IBA
10/2011
1
TNF-Related Apoptosis-Inducing Ligand
IBA
10/2011
1
Interferon-gamma (Interferon, gamma)
IBA
08/2010
1
Antineoplastic Agents (Antineoplastics)
IBA
01/2010
1
Oxazolone
IBA
06/2009
1
Interleukin-12 (IL 12)
IBA
06/2009
1
Peptidoglycan (Murein)
IBA
06/2009
1
Cyclooxygenase 2 (Cyclooxygenase-2)
IBA
02/2008
1
Dinoprostone (PGE2)
FDA Link
02/2008
1
Interleukin-23 (Interleukin 23)
IBA
02/2008
1
Interleukin-21 Receptors
IBA
01/2007
Therapy/Procedure
7
Therapeutics
01/2023 - 10/2011
1
Biological Therapy
05/2021
1
Mediterranean Diet
01/2021
1
Continuous Positive Airway Pressure
01/2020
1
Artificial Respiration (Mechanical Ventilation)
01/2020
1
Respiratory Therapy (Therapy, Respiratory)
01/2020